Consonance Capital Partners

Q: Where is Consonance Capital Partners located?

Consonance Capital Partners's headquarters are located at 1370 Avenue of the Americas Ste 3301, New York, New York, 10019, United States

Q: What is Consonance Capital Partners's phone number?

Consonance Capital Partners's phone number is (212) 660-8060

Q: What is Consonance Capital Partners's official website?

Consonance Capital Partners's official website is www.consonancecapital.com

Q: What is Consonance Capital Partners's Revenue?

Consonance Capital Partners's revenue is <$5 Million

Q: What is Consonance Capital Partners's SIC code?

Consonance Capital Partners's SIC: 67,679

Q: What is Consonance Capital Partners's NAICS code?

Consonance Capital Partners's NAICS: 52,523

Q: How many employees does Consonance Capital Partners have?

Consonance Capital Partners has <25 employees

Q: What industry does Consonance Capital Partners belong to?

Consonance Capital Partners is in the industry of: Finance General , Finance

Q: What is Consonance Capital Partners competition?

Consonance Capital Partners top competitors include: Tecum Capital Management Inc , Lexington Partners Inc , Veronis Suhler Stevenson Ltd , Axio Jensen Partners Ltd

Q: Who is the CEO of Consonance Capital Partners?

Consonance Capital Partners's CEO is Cindy Valderrama

Finance · New York, United States · <25 Employees

Consonance Capital Partners invests in private companies in the lower middle market of the U.S. healthcare industry with an emphasis on businesses driving efficiency, cost containment and high quality clinical care to patients. Consonance Capital Partners participates in growth equity, leveraged buyout, and recapitalization transactions. The private equity fund is associated with Consonance Capital Management, a healthcare-focused long/short public equity manager, and together Consonance Capital has approximately $2 billion of assets under management.Read More

Contact

Who is Consonance Capital Partners

Headquarters

1370 Avenue of the Americas Ste 3301, New York, New York, 10019, United States

Phone Number

(212) 660-8060

Website

www.consonancecapital.com

Revenue

<$5M

Industry

Finance General

Finance

Is this data correct?

View contact profiles from Consonance Capital Partners

Top Competitors of Consonance Capital Partners

Tecum Capital Management Inc
<25
<$5M
1
Lexington Partners Inc
55
$20.7M
2
Veronis Suhler Stevenson Ltd
31
$11.2M
3
Axio Jensen Partners Ltd
<25
<$5M
4
Cedar Springs Capital LLC
<25
<$5M
5
Hunter Equity Capital LLC
<25
<$5M
6

Consonance Capital Partners Org Chart

Phone

Gabriela Boland

Chief Financial Officer

Phone

Kevin Livingston

Partner & Chief Operating Of...

Phone

View Email Formats for Consonance Capital Partners

Consonance Capital Partners News & Media

Consonance Capital Partners Announces Partnership Promotions
NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners (CCP), a leading U.S. healthcare focused private equity firm, is pleased to announce that Javier Starkand and Sean Breen have been promoted to Partner. Both Javier and Sean joined CCP in 2012 and had previously worked with the Founders prior to CCP. Stephen McKenna, Managing Partner and Co-Founder of CCP said, “We’re thrilled to recognize these two impressive individuals who have contributed substantially to the firm’s success.” Benjamin Ed
Jun 15, 2020
www.businesswire.com
Consonance Capital Partners Completes Sale of Turn-Key Health
NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners (“Consonance”), a leading healthcare-focused private equity manager, announced today that it completed the sale of Turn-Key Health (“Turn-Key”) to CareCentrix. Terms of the transaction were not disclosed. Turn-Key is a leading community-based palliative care company serving health plans, hospitals, and physicians. The Company was founded by Andy Horowitz, CEO of Enclara Healthcare, and was spun out and retained upon Enclara’s sale to Humana
May 4, 2020
www.businesswire.com
Consonance Capital Partners hits USD856m hardcap for healthcare fund
28th Apr 2020 - 1:04pm Consonance Capital Partners hits USD856m hardcap for healthcare fund Submitted By Karin Wasteson | 28/04/2020 - 1:04pm New York-based healthcare private equity firm Consonance Capital Partners has held a final close of Consonance Private Equity II at its USD856 million hardcap. Fund II, which will focus on investments in US healthcare companies in the lower and middle markets, closed on 8 April 2020 at its hard cap in under three
Apr 28, 2020
www.privateequitywire.co.uk
Consonance Capital Partners Closes Fund II at Hard Cap of $856 Million
NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners, a leading U.S.-based healthcare private equity firm, today announced the final close of Consonance Private Equity II, L.P. (“Fund II”). Fund II closed at its hard cap of $856 million (inclusive of the GP commitment) in under three months from its initial close. Consistent with its predecessor fund, Fund II will focus on investments in U.S. healthcare companies in the lower and middle markets. Commenting on the close of Fund
Apr 27, 2020
www.businesswire.com
 Consonance Capital Management Announces Promotion of Gabriela Franco-Boland to Chief Financial Officer
NEW YORK--(BUSINESS WIRE)--Consonance Capital Management (CCM), the public equity life sciences manager of Consonance Capital, announced today that Gabriela Franco-Boland has been promoted to Chief Financial Officer (CFO). Ms. Franco-Boland previously served as CCM’s Vice President of Finance. Kevin Livingston, Partner and member of the Investment Committee of CCM, said, “It has been a pleasure working with Gabriela over the years as she has grown remarkably at Consonance Capital Management. He
Feb 25, 2020
www.businesswire.com